Aug 2026· Mechanisms of Ageing and Development· pp.
112240
· 0 citations· 33 references
Medicine
TL;DR
This work constructed a heterogeneous stacked ensemble survival model based on DNAm data obtained from the Framingham Heart Study and constructed a survival prediction model based on the fusion of five complementary survival models by means of a neural network meta-learner.
Abstract
Aging is a multifactorial process that is best described in terms of the progressive acquisition of multiple layers of phenotypic changes, such as epigenetic modifications, inflammation, and metabolic dysregulation. DNA methylation clocks have been extensively used to construct epigenetic clocks based on the DNAm profiles that can be used to estimate biological age and predict age-associated outcomes. Nevertheless, the vast majority of clocks constructed so far have been based on linear models, which are unlikely to fully account for the heterogeneity and non-linearity of survival-related DNAm signatures. In this work, we constructed a heterogeneous stacked ensemble survival model based on DNAm data obtained from the Framingham Heart Study. We first identified 190 CpG loci using elastic net Cox regression and subsequently constructed a survival prediction model based on the fusion of five complementary survival models by means of a neural network meta-learner. The prediction power of the survival model was evaluated in an external validation cohort, where we observed strong performance for predicting all-cause mortality that significantly exceeded PhenoAge and was statistically comparable to GrimAge. These performance estimates were derived in cohorts of European ancestry and externally validated in postmenopausal women aged 50-79 years, and should therefore be interpreted as applicable only to demographically similar populations.
We developed an interpretable blood-based epigenetic clock to estimate DNA methylation age and identify disease-specific DNA methylation alterations. Using 8233 Illumina methylomes from healthy controls and nine age-associated diseases, we used ridge selection to retain 4855 CpG sites and benchmarked 20 regression...
Rajarshi Mandal, Ning Xie, G. Alterovitz· npj Aging· 0 citations
Background: DNA methylation (DNAm) signatures capture cumulative lifestyle exposures and biological aging. This prospective study evaluated whether DNAm-based scores and epigenetic aging clocks are associated with clinical outcomes and mortality in a multinational cohort of patients with heart failure (HF). Methods: We...
P. Meyre, M. Chong, E. Shemesh et al.· medRxiv· 0 citations
Epigenetic aging clocks based on DNA methylation patterns across the genome have emerged as a potential biomarker for risk of age-related diseases, like Alzheimer’s disease (AD), and environmental and social stressors. However, methylation clocks have not been comprehensively validated in genetically diverse individual...
Analysis of DNA methylation in mammalian blood reveals fundamental links between epigenetic regulation during development, aging, and chronic diseases and develops epigenetic clocks that predict expected mortality across species and tissues and are effective in detecting a range of disease models.
Stanislav Tikhonov, Sergey E. Dmitriev· bioRxiv· 0 citations